Haryana firm booked for syphoning cough syrup bottles to

Image
Press Trust of India Chandigarh
Last Updated : Mar 02 2014 | 5:45 PM IST
Haryana state food and drug regulators have unearthed a racket of alleged diversion and transportation of more than two lakh bottles of a popular cough syrup by a Hisar-based firm to Bangladesh.
State's Department of Food and Drugs Administration (FDA) today said more than 2 lakh bottles of the cough syrup supplied by a leading pharmaceutical company to a Hisar-based firm - M/s J P Medicose - were found to have been diverted to Bangladesh illegally by the firm in connivance with a fictious Bhiwani-based medicine wholesaler.
State Drug Controller G L Singhal said investigations by the FDA revealed that the huge quantities of the cough syrup were supplied by the pharma company directly to the Hisar- based dealer, who had further shown to have supplied the entire stocks to a Bhiwani-based unlicensed medicine trader, whose licenses had expired in 2008.
"The entire sales were found to have been made to this Bhiwani-based firm without any supply order and shown to have been made against cash payment," Singhal said.
He said that on further investigations, it was found that the entire sale was fake as the firm to which sales had been made was non-existent.
FIR under various provisions of Narcotic Drugs and Psychotropic Substances Act, 1985 has been registered against the Hisar-based firm and its owner for illicit transshipment, a statement by state government said today.
The premises of the firm has also been sealed.
Meanwhile, the FDA authorities said investigations into the matter led to another case of 1.5 lakh bottles of the cough syrup being supplied by the pharma company to another Ambala-based medicine trader, M/S Laxmi Drugs Store, who also allegedly syphoned off the entire stocks illicitly and prepared fake documents to have sold to a wholesaler who never purchased any of the product.
The department has booked store's owner under the NDPS Act and various provisions of the IPC and sealed its premises.
Further investigations in to the cases are on.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 02 2014 | 5:45 PM IST

Next Story